Notice2022-22486
Advisory Commission on Childhood Vaccines Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 17, 2022
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
The Advisory Commission on Childhood Vaccines (ACCV) provides advice and recommendations to the Secretary of HHS (Secretary) on policy, program development, and other issues related to the implementation of the National Vaccine Injury Compensation Program (VICP) and concerning other matters as described under the Public Health Service Act. To ensure compliance with the statutory requirement that the ACCV meet not less than four times per year, this notice announces that the ACCV meeting originally scheduled for March 3, 2022, has been rescheduled for December 2, 2022.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 199 (Monday, October 17, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 199 (Monday, October 17, 2022)]
[Notices]
[Page 62861]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-22486]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Commission on Childhood Vaccines Meeting
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Advisory Commission on Childhood Vaccines (ACCV) provides
advice and recommendations to the Secretary of HHS (Secretary) on
policy, program development, and other issues related to the
implementation of the National Vaccine Injury Compensation Program
(VICP) and concerning other matters as described under the Public
Health Service Act. To ensure compliance with the statutory requirement
that the ACCV meet not less than four times per year, this notice
announces that the ACCV meeting originally scheduled for March 3, 2022,
has been rescheduled for December 2, 2022.
DATES: The ACCV meeting will be held on December 2, 2022, from 1:00
p.m.-4:00 p.m. Eastern Time.
ADDRESSES: This meeting will be held by Zoom webinar.
<bullet> Webinar link: <a href="https://hrsa-gov.zoomgov.com/j/1603695024?pwd=ZG4rUWw0NUlTN2d0OWRZWVJjVmNIZz09">https://hrsa-gov.zoomgov.com/j/1603695024?pwd=ZG4rUWw0NUlTN2d0OWRZWVJjVmNIZz09</a>.
<bullet> Conference call-in number: 833 568 8864, Meeting ID: 160
369 5024, Passcode: 72471327.
FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison,
ACCV, 5600 Fishers Lane, Rockville, Maryland 20857, telephone: (301)
945-9386 or email: <a href="/cdn-cgi/l/email-protection#bbfaf8f8edfbf3e9e8fa95dcd4cd"><span class="__cf_email__" data-cfemail="2a6b69697c6a6278796b044d455c">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: All 2022 ACCV meetings were originally
announced in the Federal Register, Vol. 87, No. 20 on Monday, January
31, 2022, (FR Doc. 2022-01848 Filed 1-28-22), and the notice canceling
the March 3, 2022, meeting was published on February 28, 2022 (FR Doc.
2022-04127 Filed 2-25-22).
Since priorities dictate ACCV meeting times, be advised that start
times, end times, and agenda items are subject to change. Agenda items
may include but are not limited to, updates from the Division of Injury
Compensation Programs (HRSA), Torts Branch (Department of Justice),
Office of Infectious Disease and HIV/AIDS Policy (HHS), Immunization
Safety Office (Centers for Disease Control and Prevention), National
Institute of Allergy and Infectious Diseases (National Institutes of
Health) and Center for Biologics, Evaluation and Research (Food and
Drug Administration). Refer to the ACCV website at <a href="https://www.hrsa.gov/advisory-committees/vaccines/index.html">https://www.hrsa.gov/advisory-committees/vaccines/index.html</a> for all current
and updated information concerning the ACCV meeting, including draft
agendas and meeting materials that will be posted 5 calendar days
before the meeting.
The ACCV meeting will be public, and members of the public will
have the opportunity to provide comments. Public participants may
submit written statements in advance of the scheduled meeting. Oral
comments will be honored in the order they are requested and may be
limited as time allows. Requests to submit a written statement or make
oral comments to the ACCV should be sent to Pita Gomez using the
contact information above at least 5 business days before the meeting
date.
Individuals who need special assistance or another reasonable
accommodation should notify Pita Gomez using the contact information
listed above at least 10 business days before the meeting they wish to
attend.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-22486 Filed 10-14-22; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 17, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.